Certara (NASDAQ:CERT) Earns Market Perform Rating from Analysts at BMO Capital Markets

Analysts at BMO Capital Markets started coverage on shares of Certara (NASDAQ:CERTGet Free Report) in a research report issued to clients and investors on Thursday, MarketBeat.com reports. The brokerage set a “market perform” rating and a $9.00 price target on the stock. BMO Capital Markets’ target price points to a potential upside of 6.58% from the stock’s previous close.

A number of other research firms have also recently commented on CERT. Barclays reduced their price target on Certara from $16.00 to $14.00 and set an “overweight” rating for the company in a report on Friday, November 7th. KeyCorp raised their price target on shares of Certara from $15.00 to $16.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Certara in a research report on Wednesday, October 8th. Wall Street Zen raised shares of Certara from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Finally, Craig Hallum initiated coverage on Certara in a report on Monday, September 29th. They set a “buy” rating and a $16.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $14.67.

Get Our Latest Research Report on Certara

Certara Stock Up 2.0%

CERT traded up $0.16 during trading hours on Thursday, reaching $8.44. 225,313 shares of the stock traded hands, compared to its average volume of 1,773,533. The company has a market cap of $1.34 billion, a price-to-earnings ratio of 120.43 and a beta of 1.44. Certara has a fifty-two week low of $8.13 and a fifty-two week high of $15.69. The firm’s fifty day simple moving average is $11.64 and its two-hundred day simple moving average is $11.37. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.09 and a quick ratio of 2.09.

Certara (NASDAQ:CERTGet Free Report) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.03. The firm had revenue of $104.62 million for the quarter, compared to the consensus estimate of $104.53 million. Certara had a net margin of 2.62% and a return on equity of 5.18%. During the same period in the previous year, the firm posted $0.13 earnings per share. Certara has set its FY 2025 guidance at 0.450-0.470 EPS. As a group, analysts forecast that Certara will post 0.28 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction on Tuesday, September 9th. The stock was sold at an average price of $10.92, for a total transaction of $559,366.08. Following the transaction, the insider owned 73,979 shares of the company’s stock, valued at approximately $807,850.68. This represents a 40.91% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.33% of the stock is owned by company insiders.

Hedge Funds Weigh In On Certara

Institutional investors have recently bought and sold shares of the company. Principal Financial Group Inc. grew its holdings in shares of Certara by 2.4% during the first quarter. Principal Financial Group Inc. now owns 543,958 shares of the company’s stock worth $5,385,000 after purchasing an additional 12,513 shares during the last quarter. Envestnet Asset Management Inc. boosted its holdings in shares of Certara by 23.5% during the first quarter. Envestnet Asset Management Inc. now owns 511,235 shares of the company’s stock valued at $5,061,000 after acquiring an additional 97,179 shares during the period. Brown Advisory Inc. acquired a new position in shares of Certara during the first quarter valued at approximately $238,000. Arizona State Retirement System raised its holdings in Certara by 12.9% during the 1st quarter. Arizona State Retirement System now owns 36,895 shares of the company’s stock worth $365,000 after buying an additional 4,210 shares during the period. Finally, Private Advisor Group LLC increased its position in Certara by 4.0% in the 1st quarter. Private Advisor Group LLC now owns 24,517 shares of the company’s stock worth $243,000 after purchasing an additional 949 shares during the last quarter. 73.96% of the stock is owned by hedge funds and other institutional investors.

Certara Company Profile

(Get Free Report)

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

Read More

Analyst Recommendations for Certara (NASDAQ:CERT)

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.